These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15707388)

  • 1. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events.
    Hofman MK; Princen HM; Zwinderman AH; Jukema JW
    Clin Sci (Lond); 2005 Jun; 108(6):539-45. PubMed ID: 15707388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
    Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
    Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis.
    Agema WR; Wouter Jukema J; de Maat MP; Zwinderman AH; Kastelein JJ; Rabelink TJ; van der Wall EE
    Thromb Haemost; 2004 May; 91(5):986-90. PubMed ID: 15116260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals.
    Hofman MK; Groenendijk M; Verkuijlen PJ; Jonkers IJ; Mohrschladt MF; Smelt AH; Princen HM
    Eur J Hum Genet; 2004 Nov; 12(11):935-41. PubMed ID: 15241483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Mol Genet Metab; 2008 May; 94(1):83-9. PubMed ID: 18178499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter variant -204A > C of the cholesterol 7α-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells.
    De Castro-Orós I; Pampín S; Cofán M; Mozas P; Pintó X; Salas-Salvadó J; Rodríguez-Rey JC; Ros E; Civeira F; Pocoví M
    Clin Nutr; 2011 Apr; 30(2):239-46. PubMed ID: 20884100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.
    Boekholdt SM; Agema WR; Peters RJ; Zwinderman AH; van der Wall EE; Reitsma PH; Kastelein JJ; Jukema JW;
    Circulation; 2003 May; 107(19):2416-21. PubMed ID: 12742999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin.
    Kajinami K; Brousseau ME; Ordovas JM; Schaefer EJ
    Atherosclerosis; 2005 Jun; 180(2):407-15. PubMed ID: 15910869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
    Srivastava A; Choudhuri G; Mittal B
    Metabolism; 2010 Jun; 59(6):767-73. PubMed ID: 20005541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Hagiwara T; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Res; 2005 Apr; 65(7):2979-82. PubMed ID: 15805302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ
    N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
    Shiffman D; Sabatine MS; Louie JZ; Kirchgessner TG; Iakoubova OA; Campos H; Devlin JJ; Sacks FM
    Am J Cardiol; 2010 May; 105(9):1300-5. PubMed ID: 20403483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin.
    Alipour A; Cabezas MC; Elte JW; Vallvé JC; Ribalta J; Zwinderman AH; Defesche JC; Jukema JW
    Atherosclerosis; 2011 Mar; 215(1):125-9. PubMed ID: 21211797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).
    Jukema JW; Bruschke AV; van Boven AJ; Reiber JH; Bal ET; Zwinderman AH; Jansen H; Boerma GJ; van Rappard FM; Lie KI
    Circulation; 1995 May; 91(10):2528-40. PubMed ID: 7743614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.
    Tabata S; Yin G; Ogawa S; Yamaguchi K; Mineshita M; Kono S
    Cancer Sci; 2006 May; 97(5):406-10. PubMed ID: 16630139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
    de Maat MP; Jukema JW; Ye S; Zwinderman AH; Moghaddam PH; Beekman M; Kastelein JJ; van Boven AJ; Bruschke AV; Humphries SE; Kluft C; Henney AM
    Am J Cardiol; 1999 Mar; 83(6):852-6. PubMed ID: 10190398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.
    Gu GL; Xu XL; Yang QY; Zeng RL
    Med Sci Monit; 2014 Dec; 20():2824-9. PubMed ID: 25547030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.